Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-α via the p38 mitogen-activated protein kinase pathway

Yanmin Zhang, Brittney Shea Herbert, Raja Shekhar Gangaraju, David A. Ingram, Mervin C. Yoder, Matthias Clauss, Jalees Rehman

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Senescence of endothelial cells increases with systemic aging and is thought to contribute to the development of atherosclerosis. Cell therapy with highly proliferative endothelial progenitor cells (EPCs) is an emerging therapeutic option to promote endothelial regeneration, but little is known about their senescence and their vulnerability to inflammatory stressors. We therefore studied the senescence of proliferative human EPCs and investigated the effects of the proinflammatory cytokine tumor necrosis factor-α (TNF-α) on their senescence. Human EPCs had a significantly lower rate of senescence at baseline, compared with that of mature endothelial cells. However, EPCs up-regulated the expression of the senescence-associated cell cycle arrest protein p16INK4a and markedly increased measured senescence levels when exposed to chronic TNF-α treatment. Analysis of telomere length showed that the increases in senescence were not related to changes in telomere length. Inhibition of the p38 mitogen-activated protein kinase pathway blocked the induction of p16INK4a and cellular senescence. In conclusion, highly proliferative EPCs have a low rate of intrinsic senescence but are vulnerable to premature senescence induction by chronic proinflammatory stimulation. These findings will lead to a better understanding of physiological endothelial regeneration as well as to targeted therapies with the aim of promoting endothelial regeneration through endothelial progenitor cells.

Original languageEnglish (US)
Pages (from-to)1358-1365
Number of pages8
JournalFASEB Journal
Volume23
Issue number5
DOIs
StatePublished - May 1 2009

Fingerprint

Endothelial cells
p38 Mitogen-Activated Protein Kinases
Tumor Necrosis Factor-alpha
Regeneration
Telomere
Cyclin-Dependent Kinase Inhibitor p16
Endothelial Cells
Endothelial Progenitor Cells
Cell Cycle Proteins
Cell Aging
Cell- and Tissue-Based Therapy
Cell Cycle Checkpoints
Aging of materials
Cytokines
Atherosclerosis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-α via the p38 mitogen-activated protein kinase pathway. / Zhang, Yanmin; Herbert, Brittney Shea; Gangaraju, Raja Shekhar; Ingram, David A.; Yoder, Mervin C.; Clauss, Matthias; Rehman, Jalees.

In: FASEB Journal, Vol. 23, No. 5, 01.05.2009, p. 1358-1365.

Research output: Contribution to journalArticle

Zhang, Yanmin ; Herbert, Brittney Shea ; Gangaraju, Raja Shekhar ; Ingram, David A. ; Yoder, Mervin C. ; Clauss, Matthias ; Rehman, Jalees. / Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-α via the p38 mitogen-activated protein kinase pathway. In: FASEB Journal. 2009 ; Vol. 23, No. 5. pp. 1358-1365.
@article{771d133276384d2a8fffbc6078fa0442,
title = "Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-α via the p38 mitogen-activated protein kinase pathway",
abstract = "Senescence of endothelial cells increases with systemic aging and is thought to contribute to the development of atherosclerosis. Cell therapy with highly proliferative endothelial progenitor cells (EPCs) is an emerging therapeutic option to promote endothelial regeneration, but little is known about their senescence and their vulnerability to inflammatory stressors. We therefore studied the senescence of proliferative human EPCs and investigated the effects of the proinflammatory cytokine tumor necrosis factor-α (TNF-α) on their senescence. Human EPCs had a significantly lower rate of senescence at baseline, compared with that of mature endothelial cells. However, EPCs up-regulated the expression of the senescence-associated cell cycle arrest protein p16INK4a and markedly increased measured senescence levels when exposed to chronic TNF-α treatment. Analysis of telomere length showed that the increases in senescence were not related to changes in telomere length. Inhibition of the p38 mitogen-activated protein kinase pathway blocked the induction of p16INK4a and cellular senescence. In conclusion, highly proliferative EPCs have a low rate of intrinsic senescence but are vulnerable to premature senescence induction by chronic proinflammatory stimulation. These findings will lead to a better understanding of physiological endothelial regeneration as well as to targeted therapies with the aim of promoting endothelial regeneration through endothelial progenitor cells.",
author = "Yanmin Zhang and Herbert, {Brittney Shea} and Gangaraju, {Raja Shekhar} and Ingram, {David A.} and Yoder, {Mervin C.} and Matthias Clauss and Jalees Rehman",
year = "2009",
month = "5",
day = "1",
doi = "10.1096/fj.08-110296",
language = "English (US)",
volume = "23",
pages = "1358--1365",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "5",

}

TY - JOUR

T1 - Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-α via the p38 mitogen-activated protein kinase pathway

AU - Zhang, Yanmin

AU - Herbert, Brittney Shea

AU - Gangaraju, Raja Shekhar

AU - Ingram, David A.

AU - Yoder, Mervin C.

AU - Clauss, Matthias

AU - Rehman, Jalees

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Senescence of endothelial cells increases with systemic aging and is thought to contribute to the development of atherosclerosis. Cell therapy with highly proliferative endothelial progenitor cells (EPCs) is an emerging therapeutic option to promote endothelial regeneration, but little is known about their senescence and their vulnerability to inflammatory stressors. We therefore studied the senescence of proliferative human EPCs and investigated the effects of the proinflammatory cytokine tumor necrosis factor-α (TNF-α) on their senescence. Human EPCs had a significantly lower rate of senescence at baseline, compared with that of mature endothelial cells. However, EPCs up-regulated the expression of the senescence-associated cell cycle arrest protein p16INK4a and markedly increased measured senescence levels when exposed to chronic TNF-α treatment. Analysis of telomere length showed that the increases in senescence were not related to changes in telomere length. Inhibition of the p38 mitogen-activated protein kinase pathway blocked the induction of p16INK4a and cellular senescence. In conclusion, highly proliferative EPCs have a low rate of intrinsic senescence but are vulnerable to premature senescence induction by chronic proinflammatory stimulation. These findings will lead to a better understanding of physiological endothelial regeneration as well as to targeted therapies with the aim of promoting endothelial regeneration through endothelial progenitor cells.

AB - Senescence of endothelial cells increases with systemic aging and is thought to contribute to the development of atherosclerosis. Cell therapy with highly proliferative endothelial progenitor cells (EPCs) is an emerging therapeutic option to promote endothelial regeneration, but little is known about their senescence and their vulnerability to inflammatory stressors. We therefore studied the senescence of proliferative human EPCs and investigated the effects of the proinflammatory cytokine tumor necrosis factor-α (TNF-α) on their senescence. Human EPCs had a significantly lower rate of senescence at baseline, compared with that of mature endothelial cells. However, EPCs up-regulated the expression of the senescence-associated cell cycle arrest protein p16INK4a and markedly increased measured senescence levels when exposed to chronic TNF-α treatment. Analysis of telomere length showed that the increases in senescence were not related to changes in telomere length. Inhibition of the p38 mitogen-activated protein kinase pathway blocked the induction of p16INK4a and cellular senescence. In conclusion, highly proliferative EPCs have a low rate of intrinsic senescence but are vulnerable to premature senescence induction by chronic proinflammatory stimulation. These findings will lead to a better understanding of physiological endothelial regeneration as well as to targeted therapies with the aim of promoting endothelial regeneration through endothelial progenitor cells.

UR - http://www.scopus.com/inward/record.url?scp=69249124009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249124009&partnerID=8YFLogxK

U2 - 10.1096/fj.08-110296

DO - 10.1096/fj.08-110296

M3 - Article

VL - 23

SP - 1358

EP - 1365

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 5

ER -